ST. LUKES HOSPITAL
1. Target Overview & Investment Thesis
ST. LUKES HOSPITAL is a 633-bed large academic medical center in LEHIGH, PA with $8.94B in net patient revenue and a 87.9% operating margin. The hospital serves a payer mix of 26.7% Medicare, 6.8% Medicaid, and 66.6% commercial.
Thesis: Platform Growth. Our ML models identify $658.4M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 87.9% to 95.3% (+736bps).
| Net Revenue HCRIS | $8.94B |
| Current EBITDA COMPUTED | $7.86B |
| Operating Margin COMPUTED | 87.9% |
| Occupancy HCRIS | 71.5% |
| Revenue / Bed COMPUTED | $14.1M |
| Net-to-Gross HCRIS | 100.0% |
| Distress Probability ML | 34.8% |
2. Market Context & Competitive Position
PA has 225 Medicare-certified hospitals with a median operating margin of -4.4%. The target's margin of 87.9% places it above the state median. Among 28 size-comparable peers (316-1266 beds), the median margin is -9.8%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (316-1266), prioritizing same-state peers. 28 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| ST. LUKES HOSPITAL (Target) | PA | 633 | $8.94B | 87.9% |
| HOSPITAL OF THE UNIV OF PENNA | PA | 1051 | $3.36B | -12.8% |
| LEHIGH VALLEY | PA | 1190 | $2.84B | -5.9% |
| THE CHILDRENS HOSPITAL OF PHIL | PA | 667 | $2.70B | -26.8% |
| UPMC - PRESBYTERIAN SHADYSIDE | PA | 1141 | $2.24B | -23.0% |
| MILTON S. HERSHEY MEDICAL CENT | PA | 616 | $2.08B | -2.8% |
| TEMPLE UNIVERSITY HOSPITAL | PA | 761 | $1.99B | 0.8% |
| THOMAS JEFFERSON UNIV. HOSPITA | PA | 868 | $1.93B | -23.1% |
| GEISINGER MEDICAL CENTER | PA | 525 | $1.58B | 4.1% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $658.4M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $187.8M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $178.9M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $177.1M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $108.8M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $5.7M | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $7.86B |
| + RCM Uplift | +$658.4M |
| Pro Forma EBITDA | $8.52B |
| Current Margin | 87.9% |
| Pro Forma Margin | 95.3% |
| WC Released (1x) | $343.1M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $12.10B | $58.46B | 4.83x | 37.0% |
| Base (11x exit) | 10.0x | 11.0x | $12.10B | $68.24B | 5.64x | 41.3% |
| Bull Case | 9.0x | 11.0x | $10.89B | $74.34B | 6.83x | 46.8% |
| Bull (12x exit) | 9.0x | 12.0x | $10.89B | $84.31B | 7.74x | 50.6% |
| Bear Case | 11.0x | 10.0x | $13.31B | $51.24B | 3.85x | 30.9% |
| Bear (11x exit) | 11.0x | 11.0x | $13.31B | $60.69B | 4.56x | 35.4% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| Medium | Standard execution risk | RCM improvement requires management buy-in and 12-18 month implementation timeline |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 28 hospitals with 316-1266 beds
- Same-state prioritization (n=29)
- Comp margins: P25=-20.9% / P50=-9.8% / P75=-2.5%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.